Join
Live feed
·
INSIDERFilingvia Quantisnow
Pelthos Therapeutics Inc. logo

Director Davis Todd C bought $999,983 worth of shares (35,948 units at $27.82), increasing direct ownership by 90% to 75,834 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PTHS· Pelthos Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PTHS (Pelthos Therapeutics Inc.) and more on Quantisnow.